Ofatumumab

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.8, 2010-05, pp. : 1013-1019

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel approach used to determine cost effectiveness of ofatumumab

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 617, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Ofatumumab offers hope for patients with rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Ofatumumab: a guide to its use in chronic lymphocytic leukaemia

By Keating Gillian M. Lyseng-Williamson Katherine A. Sanford Mark McCormack Paul L.

Drugs & Therapy Perspectives, Vol. 28, Iss. 6, 2012-06 ,pp. : 6-9

Adis International

Access to resources Recommend Favorite

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders

By Castillo Jorge Milani Cannon Mendez-Allwood Daniel

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 491-500

Informa Healthcare

Access to resources Recommend Favorite

A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B‐cell lymphoma of the mucosa‐associated lymphoid tissue (MALT) lymphoma

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 49-55

John Wiley & Sons Inc

Access to resources Recommend Favorite